C08F8/44

METAL IONOMER COMPOSITIONS AND METHODS OF MAKING THE SAME
20220306783 · 2022-09-29 · ·

Disclosed in embodiments herein are ionomers and methods of making the same. The ionomers comprise a neutralized blend of olefin-carboxylic acid copolymers and Group II, Group IIIA, and transition metal salts. The method includes mixing an acid copolymer formed from an α-olefin monomer and an α,β-ethylenically unsaturated carboxylic acid having at least one carboxylic acid group with an amine-containing aqueous solution to form an aqueous dispersion containing an amine salt of the acid copolymer. The method further includes mixing a solution of a Group IIA , Group IIIA, or transition metal salt with the aqueous dispersion containing the amine salt of the acid copolymer to exchange at least a portion of the amine salt for the Group IIA , Group IIIA, or transition metal salt, thereby forming the ionic copolymer.

Aqueous solution of cationic copolymers derived from acrylamide, preparation method and use
09725532 · 2017-08-08 · ·

The present invention relates to a process for the preparation of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer, comprising the following steps: Hofmann degradation reaction on a (co)polymer based on at least one non-ionic monomer chosen from the group including acrylamide, methacrylamide, N,N-dimethylacrylamide, and acrylonitrile; post-processing of the resulting aqueous polymer solution of viscosity V1; characterized in that the post processing comprises the following successive steps: obtaining of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer derived from the Hofmann degradation reaction; post-processing of this aqueous polymer solution; characterized in that the post processing comprises the following successive steps: (a) adjustment of the pH of the aqueous polymer solution to a value greater than or equal to 5.5; (b) decrease of the pH of the aqueous polymer solution to a value between 2 and 5. The invention also concerns the use of this polymer solution as a flocculant, retention and/or drainage agent, and dry strength resistance in a paper manufacturing process.

Aqueous solution of cationic copolymers derived from acrylamide, preparation method and use
09725532 · 2017-08-08 · ·

The present invention relates to a process for the preparation of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer, comprising the following steps: Hofmann degradation reaction on a (co)polymer based on at least one non-ionic monomer chosen from the group including acrylamide, methacrylamide, N,N-dimethylacrylamide, and acrylonitrile; post-processing of the resulting aqueous polymer solution of viscosity V1; characterized in that the post processing comprises the following successive steps: obtaining of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer derived from the Hofmann degradation reaction; post-processing of this aqueous polymer solution; characterized in that the post processing comprises the following successive steps: (a) adjustment of the pH of the aqueous polymer solution to a value greater than or equal to 5.5; (b) decrease of the pH of the aqueous polymer solution to a value between 2 and 5. The invention also concerns the use of this polymer solution as a flocculant, retention and/or drainage agent, and dry strength resistance in a paper manufacturing process.

Aqueous solution of cationic copolymers derived from acrylamide, preparation method and use
09725532 · 2017-08-08 · ·

The present invention relates to a process for the preparation of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer, comprising the following steps: Hofmann degradation reaction on a (co)polymer based on at least one non-ionic monomer chosen from the group including acrylamide, methacrylamide, N,N-dimethylacrylamide, and acrylonitrile; post-processing of the resulting aqueous polymer solution of viscosity V1; characterized in that the post processing comprises the following successive steps: obtaining of an aqueous polymer solution containing at least one cationic or amphoteric (co)polymer derived from the Hofmann degradation reaction; post-processing of this aqueous polymer solution; characterized in that the post processing comprises the following successive steps: (a) adjustment of the pH of the aqueous polymer solution to a value greater than or equal to 5.5; (b) decrease of the pH of the aqueous polymer solution to a value between 2 and 5. The invention also concerns the use of this polymer solution as a flocculant, retention and/or drainage agent, and dry strength resistance in a paper manufacturing process.

ANTIMICROBIAL AND ANTIVIRAL PRODUCT
20170215416 · 2017-08-03 ·

An antimicrobial and/or antiviral polymer is provided. The polymer is a modified polymer of a precursor polymer that comprises nitrogen atoms. The precursor polymer is modified into the antimicrobial and/or antiviral polymer of the present invention by substituting at least part of the nitrogen atoms with a (C.sub.1-C.sub.20) alkyl group and quaternizing at least part of the substituted nitrogen atoms. Such antimicrobial and/or antiviral polymers bind strongly and non-covalently to surfaces, rendering the surface antimicrobial and/or antiviral.

ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS MEDICINE, PARTICULARLY FOR PROPYLAXIS AND TREATMENT OF INFECTIONS OF RESPIRATORY TRACT CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), HUMAN RHINOVIRUSES (HRV), AND INFECTION BY INFLUENZA VIRUS TYPE A (IAV) AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO.sub.3.sup.− or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS MEDICINE, PARTICULARLY FOR PROPYLAXIS AND TREATMENT OF INFECTIONS OF RESPIRATORY TRACT CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), HUMAN RHINOVIRUSES (HRV), AND INFECTION BY INFLUENZA VIRUS TYPE A (IAV) AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO.sub.3.sup.− or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

QUATERNARY AMMONIUM AMIDE AND/OR ESTER SALTS

The invention relates to quaternary ammonium amide and/or ester salts and their use as additives, including their use in fuels, such as diesel fuel. The invention particularly relates to the use of quaternary ammonium amide and/or ester salts as detergents in diesel fuels.

QUATERNARY AMMONIUM AMIDE AND/OR ESTER SALTS

The invention relates to quaternary ammonium amide and/or ester salts and their use as additives, including their use in fuels, such as diesel fuel. The invention particularly relates to the use of quaternary ammonium amide and/or ester salts as detergents in diesel fuels.

QUATERNARY AMMONIUM AMIDE AND/OR ESTER SALTS

The invention relates to quaternary ammonium amide and/or ester salts and their use as additives, including their use in fuels, such as diesel fuel. The invention particularly relates to the use of quaternary ammonium amide and/or ester salts as detergents in diesel fuels.